Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Lipid Res ; 57(12): 2208-2216, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27707818

RESUMO

It was hypothesized that under induced lipid malabsorption/maldigestion conditions, an enriched sn-1(3)-monoacylglycerol (MAG) oil may be a better carrier for n-3 long-chain PUFAs (LC-PUFAs) compared with triacylglycerol (TAG) from fish oil. This monocentric double blinded clinical trial examined the accretion of EPA (500 mg/day) and DHA (300 mg/day) when consumed as TAG or MAG, into the erythrocytes, plasma, and chylomicrons of 45 obese (BMI ≥30 kg/m2 and ≤40 kg/m2) volunteers who were and were not administered Orlistat, an inhibitor of pancreatic lipases. Intake of MAG-enriched oil resulted in higher accretion of LC-PUFAs than with TAG, the concentrations of EPA and DHA in erythrocytes being, respectively, 72 and 24% higher at 21 days (P < 0.001). In addition, MAG increased the plasma concentration of EPA by 56% (P < 0.001) as compared with TAG. In chylomicrons, MAG intake yielded higher levels of EPA with the area under the curve (0-10 h) of EPA being 55% greater (P = 0.012). In conclusion, in obese human subjects with Orlistat-induced lipid maldigestion/malabsorption conditions, LC-PUFA MAG oil increased LC-PUFA levels in erythrocytes, plasma, and chylomicrons to a greater extent than TAG. These results indicate that MAG oil might require minimal enzymatic digestion prior to intestinal uptake and transfer across the epithelial barrier.


Assuntos
Ácidos Docosa-Hexaenoicos/farmacocinética , Ácido Eicosapentaenoico/farmacocinética , Transtornos do Metabolismo dos Lipídeos/tratamento farmacológico , Monoglicerídeos/administração & dosagem , Adulto , Fármacos Antiobesidade/efeitos adversos , Fármacos Antiobesidade/uso terapêutico , Membrana Celular/metabolismo , Quilomícrons , Ácidos Docosa-Hexaenoicos/administração & dosagem , Método Duplo-Cego , Ácido Eicosapentaenoico/administração & dosagem , Eritrócitos/metabolismo , Feminino , Óleos de Peixe/administração & dosagem , Óleos de Peixe/farmacocinética , Humanos , Lactonas/efeitos adversos , Lactonas/uso terapêutico , Transtornos do Metabolismo dos Lipídeos/induzido quimicamente , Masculino , Pessoa de Meia-Idade , Obesidade/sangue , Obesidade/tratamento farmacológico , Orlistate
2.
Bone ; 44(1): 120-4, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18926940

RESUMO

BACKGROUND: Dietary acid charge enhances bone loss. Bicarbonate or alkali diet decreases bone resorption in humans. We compared the effect of an alkaline mineral water, rich in bicarbonate, with that of an acid one, rich in calcium only, on bone markers, in young women with a normal calcium intake. METHODS: This study compared water A (per litre: 520 mg Ca, 291 mg HCO(3)(-), 1160 mg SO(4)(-), Potential Renal Acid load (PRAL) +9.2 mEq) with water B (per litre: 547 mg Ca, 2172 mg HCO(3)(-), 9 mg SO(4)(-), PRAL -11.2 mEq). 30 female dieticians aged 26.3 yrs (SD 7.3) were randomized into two groups, followed an identical weighed, balanced diet (965 mg Ca) and drank 1.5 l/d of the assigned water. Changes in blood and urine electrolytes, C-telopeptides (CTX), urinary pH and bicarbonate, and serum PTH were measured after 2 and 4 weeks. RESULTS: The two groups were not different at baseline, and showed a similar increase in urinary calcium excretion. Urinary pH and bicarbonate excretion increased with water B, but not with water A. PTH (p=0.022) and S-CTX (p=0.023) decreased with water B but not with water A. CONCLUSION: In calcium sufficiency, the acid calcium-rich water had no effect on bone resorption, while the alkaline water rich in bicarbonate led to a significant decrease of PTH and of S-CTX.


Assuntos
Álcalis/uso terapêutico , Reabsorção Óssea/tratamento farmacológico , Osso e Ossos/metabolismo , Cálcio da Dieta/uso terapêutico , Águas Minerais/uso terapêutico , Adolescente , Adulto , Bicarbonatos/urina , Osso e Ossos/patologia , Colágeno Tipo I/sangue , Jejum/urina , Feminino , Testes Hematológicos , Humanos , Concentração de Íons de Hidrogênio , Pessoa de Meia-Idade , Hormônio Paratireóideo/sangue , Peptídeos/sangue , Urinálise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA